ArticleNovel Avilamycin (cas 11051-71-1) Derivatives with Improved Polarity Generated by Targeted Gene Disruption
-
Add time:08/18/2019 Source:sciencedirect.com
The oligosaccharide antibiotics Avilamycin (cas 11051-71-1) A and C are produced by Streptomyces viridochromogenes Tü57. Both consist of a heptasaccharide chain, which is attached to a polyketide-derived dichloroisoeverninic acid moiety. They show excellent antibiotic activity against Gram-positive bacteria. Both molecules are modified by O-methylation at different positions, which contributes to poor water solubility and difficulties in galenical drug development. In order to generate novel avilamycin derivatives with improved polarity and improved pharmacokinetic properties, we generated a series of mutants with one, two, or three mutated methyltransferase genes. Based on the structure of the novel avilamycin derivatives, the exact function of three methyltransferases, AviG2, AviG5, and AviG6, involved in avilamycin biosynthesis could be assigned.
We also recommend Trading Suppliers and Manufacturers of Avilamycin (cas 11051-71-1). Pls Click Website Link as below: cas 11051-71-1 suppliers
Prev:Use of Avilamycin (cas 11051-71-1) for growth promotion and Avilamycin (cas 11051-71-1)-resistance among Enterococcus faecium from broilers in a matched case–control study in France
Next:Short communicationDetermination of Avilamycin (cas 11051-71-1) A and B in pig faeces by solid phase extraction and reverse-phase HPLC assay) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research ArticleGenes Encoding Enzymes Responsible for Biosynthesis of L-Lyxose and Attachment of Eurekanate during Avilamycin (cas 11051-71-1) Biosynthesis08/21/2019
- Research PaperBiosynthesis of the orthosomycin antibiotic Avilamycin (cas 11051-71-1) A: deductions from the molecular analysis of the avi biosynthetic gene cluster of Streptomyces viridochromogenes Tü57 and production of new antibiotics08/20/2019
- Short communicationDetermination of Avilamycin (cas 11051-71-1) A and B in pig faeces by solid phase extraction and reverse-phase HPLC assay08/19/2019
- Use of Avilamycin (cas 11051-71-1) for growth promotion and Avilamycin (cas 11051-71-1)-resistance among Enterococcus faecium from broilers in a matched case–control study in France08/17/2019
- Analytical MethodsDetermination of total Avilamycin (cas 11051-71-1) residues as dichloroisoeverninic acid in porcine muscle, fat, and liver by LC-MS/MS08/16/2019